Skip to main content
. Author manuscript; available in PMC: 2021 Aug 6.
Published in final edited form as: J Am Board Fam Med. 2021 Feb;34(Suppl):S127–S135. doi: 10.3122/jabfm.2021.S1.200464

Table 5.

Selected Clinical Prediction Rules for COVID-19 Prognosis

Study Performance in Original Study Performance in 5 US Sites
Lu et al., 20209 Low risk: 0% Low risk: 2/108 (1.8%)
Moderate risk: 6% Moderate risk: 24/359 (6.7%)
High risk: 33% High risk: 87/324 (26.9%)
Xie et al., 202010 AUROCC (derivation) = 0.893 AUROCC = 0.7981
AUROCC (test) = 0.980 Hosmer-Lemeshow P = .23
Yan et al., 202011 Low risk: 3/189 (1.6%) Low risk: 10/243 (4.1%)
High risk: 157/162 (96.9%) High risk: 85/374 (22.7%)

AUROCC, area under the receiver operating characteristic curve.

See appendix for details regarding calculation of risk scores.